# Therapeutic BCL11A enhancer gene editing to induce fetal hemoglobin in β-hemoglobinopathy patients

> **NIH NIH OT2** · BOSTON CHILDREN'S HOSPITAL · 2020 · $1,716,494

## Abstract

No abstract provided

## Key facts

- **NIH application ID:** 10090251
- **Project number:** 1OT2HL154984-01
- **Recipient organization:** BOSTON CHILDREN'S HOSPITAL
- **Principal Investigator:** Daniel Evan Bauer
- **Activity code:** OT2 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1,716,494
- **Award type:** 1
- **Project period:** 2020-06-18 → 2022-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10090251

## Citation

> US National Institutes of Health, RePORTER application 10090251, Therapeutic BCL11A enhancer gene editing to induce fetal hemoglobin in β-hemoglobinopathy patients (1OT2HL154984-01). Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/grant/nih/10090251. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*